SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0000950135-07-003044
Filing Date
2007-05-10
Accepted
2007-05-10 11:25:27
Documents
6

Document Format Files

Seq Description Document Type Size
1 INVERNESS MEDICAL INNOVATIONS, INC. b65446ime8vk.htm SC TO-C 14837
2 EX-99.1 PRESS RELEASE, DATED MAY 9, 2007 b65446imexv99w1.htm EX-99.1 8986
3 EX-99.2 OFFER LETTER, DATED MAY 9, 2007 b65446imexv99w2.htm EX-99.2 9442
4 EX-99.3 COMMITTMENT LETTER AMONG GENERAL ELECTRIC CAPITAL CORPORATION, UBS LOAN b65446imexv99w3.txt EX-99.3 83295
5 EX-99.4 COMMITTMENT LETTER AMONG UBS LOAN FINANCE LLC, GENERAL ELECTRIC CAPITAL b65446imexv99w4.txt EX-99.4 73401
6 EX-99.5 PROPOSED AGREEMENT AND PLAN OF MERGER b65446imexv99w5.txt EX-99.5 289966
  Complete submission text file 0000950135-07-003044.txt   481993
Mailing Address 11030 ROSELLE ST SAN DIEGO CA 92121
Business Address 11030 ROSELLE ST SAN DIEGO CA 92121 6194554808
BIOSITE INC (Subject) CIK: 0000834306 (see all company filings)

IRS No.: 330288606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-50351 | Film No.: 07835649
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filed by) CIK: 0001145460 (see all company filings)

IRS No.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2835 In Vitro & In Vivo Diagnostic Substances